Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL)

NCT02546440 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous T Cell Lymphoma

Interventions

DRUG: Dimethyl fumarate

Sponsor

Universitätsmedizin Mannheim

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]